Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
15.15
-0.22 (-1.43%)
At close: Aug 14, 2026, 4:00 PM EDT
15.00
-0.15 (-0.99%)
After-hours: Aug 14, 2026, 7:34 PM EDT
Q32 Bio Market Cap
Q32 Bio has a market cap or net worth of $451.01 million as of August 14, 2026. Its market cap has increased by 1,942.82% in one year.
Market Cap
451.01M
Enterprise Value
350.03M
1-Year Change
1,942.82%
Ranking
Category
Stock Price
$15.15
ChartMarket Cap Chart
Since March 26, 2024, Q32 Bio's market cap has increased from $199.19M to $451.01M, an increase of 126.42%. That is a compound annual growth rate of 40.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 451.01M | 1,004.05% |
| Dec 31, 2025 | 40.85M | -2.51% |
| Dec 31, 2024 | 41.90M | -78.96% |
| Mar 26, 2024 | 199.19M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Prothena Corporation | 458.95M |
| Cabaletta Bio | 452.69M |
| Ocugen | 449.32M |
| Larimar Therapeutics | 443.11M |
| Puma Biotechnology | 441.35M |
| Eupraxia Pharmaceuticals | 436.74M |
| Inhibikase Therapeutics | 433.34M |
| SL Science Holding | 433.16M |